184 related articles for article (PubMed ID: 36711366)
21. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
Pei M; Zhao X; Wan G
Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
[TBL] [Abstract][Full Text] [Related]
22. Complications, Compliance, and 3-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.
Kasetty VM; Starnes DC; Sood N; Qin LG; Moses MM; Frazier HK; Singh H; Marcus DM
Ophthalmic Surg Lasers Imaging Retina; 2023 Feb; 54(2):89-96. PubMed ID: 36780633
[TBL] [Abstract][Full Text] [Related]
23. Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Glassman AR; Beaulieu WT; Maguire MG; Antoszyk AN; Chow CC; Elman MJ; Jampol LM; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2021 Jul; 139(7):725-733. PubMed ID: 33956075
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
[TBL] [Abstract][Full Text] [Related]
25. Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial.
Arevalo JF; Lasave AF; Kozak I; Al Rashaed S; Al Kahtani E; Maia M; Farah ME; Cutolo C; Brito M; Osorio C; Navarro P; Wu L; Berrocal MH; Morales-Canton V; Serrano MA; Graue-Wiechers F; Sabrosa NA; Alezzandrini AA; Gallego-Pinazo R;
Am J Ophthalmol; 2019 Nov; 207():279-287. PubMed ID: 31095954
[TBL] [Abstract][Full Text] [Related]
26. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.
Jirawison C; Ittipunkul N
J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial.
Jorge DM; Tavares Neto JEDS; Poli-Neto OB; Scott IU; Jorge R
Int J Retina Vitreous; 2021 Apr; 7(1):35. PubMed ID: 33902755
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
Hu L; Chen Q; Du Z; Wang W; Zhao G
Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation.
Park YJ; Ahn J; Kim TW; Park SJ; Joo K; Park KH; Shin JY
Eye (Lond); 2021 Nov; 35(11):3056-3063. PubMed ID: 33420422
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal bevacizumab for proliferative diabetic retinopathy with new dense vitreous hemorrhage after full panretinal photocoagulation.
Sinawat S; Rattanapakorn T; Sanguansak T; Yospaiboon Y; Sinawat S
Eye (Lond); 2013 Dec; 27(12):1391-6. PubMed ID: 24037235
[TBL] [Abstract][Full Text] [Related]
32. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab.
Hu X; Pan Q; Zheng J; Song Z; Zhang Z
BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158
[TBL] [Abstract][Full Text] [Related]
33. Determining the Superiority of Vitrectomy vs Aflibercept for Treating Dense Diabetic Vitreous Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Quiroz-Reyes MA; Quiroz-Gonzalez EA; Quiroz-Gonzalez MA; Lima-Gómez V
Clin Ophthalmol; 2023; 17():2359-2370. PubMed ID: 37600150
[TBL] [Abstract][Full Text] [Related]
34. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).
Rizzo S; Genovesi-Ebert F; Di Bartolo E; Vento A; Miniaci S; Williams G
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):837-42. PubMed ID: 18286296
[TBL] [Abstract][Full Text] [Related]
35. COMPARISON OF THE EFFICACY AND SAFETY OF RANIBIZUMAB 0.5 MG VERSUS 1.0 MG WITH PARS PLANA VITRECTOMY FOR THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY: A Randomized Controlled Trial.
Su T; Lai D; Wu Y; Gu C; He S; Meng C; Cai C; Zhang J; Luo D; Chen J; Zheng Z; Qiu Q
Retina; 2024 Apr; 44(4):680-688. PubMed ID: 38011844
[TBL] [Abstract][Full Text] [Related]
36. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
37. Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial.
Rush RB; Velazquez JC; Rosales CR; Rush SW
Am J Ophthalmol; 2022 Oct; 242():173-180. PubMed ID: 35764103
[TBL] [Abstract][Full Text] [Related]
38. Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy.
Demir M; Oba E; Can E; Kara O; Cinar S
Ophthalmol Eye Dis; 2013; 5():11-5. PubMed ID: 23926440
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
Chen GH; Tzekov R; Mao SH; Tong YH; Jiang FZ; Li WS
Eye (Lond); 2022 Mar; 36(3):619-626. PubMed ID: 33824510
[TBL] [Abstract][Full Text] [Related]
40. Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.
Castillo J; Aleman I; Rush SW; Rush RB
Am J Ophthalmol; 2017 Nov; 183():1-10. PubMed ID: 28860046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
